Maynard Um
-
-
-
-
-
-
-
C4 Therapeutics sets cemsidomide trial timelines through 2028
-
-
-
-
-
-
-
Stephens Upgrades C4 Therapeutics (CCCC) to Overweight
-
-
-
-
-
-
-
C4 Therapeutics, Inc. (CCCC) Tops Q3 EPS by 3c
-
-
-
-
-
-
-
C4 Therapeutics Inc. (CCCC) Appoints Stephen Fawell to its Board
-
-
-
466,308 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


